The concurrent increase in CD8+ and CD4+ T cell populations and reduction in PD-L1 and TAM markers in tumor and spleen tissues (Figure 5I–M and Figure S11A–D) indicates reversal of the TAM-enriched TME. This evidence concerns the gene CD4 and neoplasm.